Drug testing your patients for marijuana
已归档的系列专辑 ("不活跃的收取点" status)
When? This feed was archived on January 03, 2024 08:08 (). Last successful fetch was on October 16, 2023 10:25 ()
Why? 不活跃的收取点 status. 我们的伺服器已尝试了一段时间,但仍然无法截取有效的播客收取点
What now? You might be able to find a more up-to-date version using the search function. This series will no longer be checked for updates. If you believe this to be in error, please check if the publisher's feed link below is valid and contact support to request the feed be restored or if you have any other concerns about this.
Manage episode 282121272 series 2854810
Today, we will be talking about marijuana and marijuana-based products in order to:
- Understand drug testing for marijuana, and why it’s important
- Examine marijuana used in concert with controlled medications for pain or ADHD
- Give some general recommendations for therapeutic drug monitoring for marijuana in patients with chronic pain using controlled substances
- For example, at a minimum such patients should be tested before opioid therapy begins, again within 1 to 3 months, and randomly over the next 12 months, and more frequently if there are unexpected results, or there are complaints or behavior changes in the patient
The episode features Quest Diagnostics Senior Medical Advisor, Dr Jeff Gudin, and Medical Science Liaison, Dr Jack Kain. They will be discussing drug testing your patients for marijuana.
----more----
You may download the PDF version of this presentation here >
To learn more, please visit QuestDrugMonitoring.com for information on our Drug Monitoring Test Directory and offerings, as well as educational resources and insights from our team of toxicology experts. At Quest Diagnostics, we are committed to providing you results and insights to support your clinical decisions.
23集单集